Lin Huang

机构：Johnson & Johnson (United States), University of Maryland, College Park · ORCID：0000-0002-4892-7871

发表论文 130 篇 · 总被引 5030 次 · h-index 26

代表论文

• Dual Targeting of Extramedullary Myeloma with Talquetamab and Teclistamab (2025 · New England Journal of Medicine · 被引 43)
• Human Infection with a Novel Tickborne Orthonairovirus Species in China (2025 · New England Journal of Medicine · 被引 33)
• Inactivation of glutathione S -transferase alpha 4 blocks Enterococcus faecalis -induced bystander effect by promoting macrophage ferroptosis (2025 · Gut Microbes · 被引 11)
• Efficacy, safety, and pharmacokinetics of teclistamab in Chinese patients with relapsed/refractory multiple myeloma from the China cohort of MajesTEC‐1 (2024 · Cancer · 被引 11)
• Safety and efficacy of talquetamab + teclistamab in patients with Relapsed/Refractory multiple myeloma from Phase 1b of redirectt-1: Results with an extended median follow-up of 3 years (2025 · Blood · 被引 9)
• Extracellular vesicles from ovarian cancer cells induce senescent lipid-laden macrophages to facilitate omental metastasis (2025 · Journal of Nanobiotechnology · 被引 7)